OBJECTIVE: To determine antemortem MRI findings associated with microinfarcts at autopsy. METHODS: Patients with microinfarcts (n = 22) and patients without microinfarcts (n = 44) who underwent antemortem MRI were identified from a dementia clinic-based, population-based, and community clinic-based autopsy cohort. The microinfarct and no-microinfarct groups were matched on age at MRI, age at death, sex, APOE status, Mini-Mental State Examination score, and pathologic diagnosis of Alzheimer disease. Brain infarcts were assessed on fluid-attenuated inversion recovery (FLAIR) MRI. White matter hyperintensities on FLAIR MRI and hippocampal volumes on T1-weighted MRI were quantified using automated methods. A subset of subjects with microinfarcts (n = 15) and a matched group of subjects without microinfarcts (n = 15) had serial T1-weighted MRIs and were included in an analysis of global and regional brain atrophy rates using automated methods. RESULTS: The presence of cortical (p = 0.03) and subcortical (p = 0.02) infarcts on antemortem MRI was associated with presence of microinfarcts at autopsy. Higher numbers of cortical (p = 0.05) and subcortical (p = 0.03) infarcts on antemortem MRI were also associated with presence of microinfarcts. Presence of microinfarcts was not associated with white matter hyperintensities and cross-sectional hippocampal volume on antemortem MRI. Whole-brain and regional precuneus, motor, and somatosensory atrophy rates were higher in subjects with microinfarcts compared to subjects without microinfarcts. CONCLUSIONS: Microinfarcts increase brain atrophy rates independent of Alzheimer disease pathology. Association between microinfarct pathology and macroinfarcts on MRI suggests either common risk factors or a shared pathophysiology and potentially common preventive targets.
OBJECTIVE: To determine antemortem MRI findings associated with microinfarcts at autopsy. METHODS:Patients with microinfarcts (n = 22) and patients without microinfarcts (n = 44) who underwent antemortem MRI were identified from a dementia clinic-based, population-based, and community clinic-based autopsy cohort. The microinfarct and no-microinfarct groups were matched on age at MRI, age at death, sex, APOE status, Mini-Mental State Examination score, and pathologic diagnosis of Alzheimer disease. Brain infarcts were assessed on fluid-attenuated inversion recovery (FLAIR) MRI. White matter hyperintensities on FLAIR MRI and hippocampal volumes on T1-weighted MRI were quantified using automated methods. A subset of subjects with microinfarcts (n = 15) and a matched group of subjects without microinfarcts (n = 15) had serial T1-weighted MRIs and were included in an analysis of global and regional brain atrophy rates using automated methods. RESULTS: The presence of cortical (p = 0.03) and subcortical (p = 0.02) infarcts on antemortem MRI was associated with presence of microinfarcts at autopsy. Higher numbers of cortical (p = 0.05) and subcortical (p = 0.03) infarcts on antemortem MRI were also associated with presence of microinfarcts. Presence of microinfarcts was not associated with white matter hyperintensities and cross-sectional hippocampal volume on antemortem MRI. Whole-brain and regional precuneus, motor, and somatosensory atrophy rates were higher in subjects with microinfarcts compared to subjects without microinfarcts. CONCLUSIONS:Microinfarcts increase brain atrophy rates independent of Alzheimer disease pathology. Association between microinfarct pathology and macroinfarcts on MRI suggests either common risk factors or a shared pathophysiology and potentially common preventive targets.
Authors: Melissa E Murray; Prashanthi Vemuri; Greg M Preboske; Matthew C Murphy; Katherine J Schweitzer; Joseph E Parisi; Clifford R Jack; Dennis W Dickson Journal: J Neuropathol Exp Neurol Date: 2012-12 Impact factor: 3.685
Authors: M Brandon Westover; Matt T Bianchi; Chunhui Yang; Julie A Schneider; Steven M Greenberg Journal: Neurology Date: 2013-03-13 Impact factor: 9.910
Authors: T H Mosley; D S Knopman; D J Catellier; N Bryan; R G Hutchinson; C A Grothues; A R Folsom; L S Cooper; G L Burke; D Liao; M Szklo Journal: Neurology Date: 2005-06-28 Impact factor: 9.910
Authors: Limor Raz; M Jayachandran; Nirubol Tosakulwong; Timothy G Lesnick; Samantha M Wille; Matthew C Murphy; Matthew L Senjem; Jeffrey L Gunter; Prashanthi Vemuri; Clifford R Jack; Virginia M Miller; Kejal Kantarci Journal: Neurology Date: 2013-02-13 Impact factor: 9.910
Authors: Kejal Kantarci; Stephen D Weigand; Scott A Przybelski; Gregory M Preboske; V Shane Pankratz; Prashanthi Vemuri; Matthew L Senjem; Matthew C Murphy; Jeffrey L Gunter; Mary M Machulda; Robert J Ivnik; Rosebud O Roberts; Bradley F Boeve; Walter A Rocca; David S Knopman; Ronald C Petersen; Clifford R Jack Journal: Neurology Date: 2013-06-12 Impact factor: 9.910
Authors: Rhoda Au; Joseph M Massaro; Philip A Wolf; Megan E Young; Alexa Beiser; Sudha Seshadri; Ralph B D'Agostino; Charles DeCarli Journal: Arch Neurol Date: 2006-02
Authors: Mekala R Raman; Nirubol Tosakulwong; Samantha M Zuk; Matthew L Senjem; Wendy M White; Julie A Fields; Michelle M Mielke; Timothy G Lesnick; Kent R Bailey; Clifford R Jack; Virginia M Miller; Vesna D Garovic; Kejal Kantarci Journal: J Hypertens Date: 2017-12 Impact factor: 4.844
Authors: David S Knopman; Michael E Griswold; Seth T Lirette; Rebecca F Gottesman; Kejal Kantarci; A Richey Sharrett; Clifford R Jack; Jonathan Graff-Radford; Andrea L C Schneider; B Gwen Windham; Laura H Coker; Marilyn S Albert; Thomas H Mosley Journal: Stroke Date: 2015-01-06 Impact factor: 7.914
Authors: Ahmed A Bahrani; David K Powell; Guoquiang Yu; Eleanor S Johnson; Gregory A Jicha; Charles D Smith Journal: J Stroke Cerebrovasc Dis Date: 2017-01-04 Impact factor: 2.136
Authors: Jonathan Graff-Radford; Mekala R Raman; Alejandro A Rabinstein; Scott A Przybelski; Timothy G Lesnick; Bradley F Boeve; Melissa E Murray; Dennis W Dickson; R Ross Reichard; Joseph E Parisi; David S Knopman; Ronald C Petersen; Clifford R Jack; Kejal Kantarci Journal: JAMA Neurol Date: 2018-02-01 Impact factor: 18.302
Authors: François De Guio; Marco Duering; Franz Fazekas; Frank-Erik De Leeuw; Steven M Greenberg; Leonardo Pantoni; Agnès Aghetti; Eric E Smith; Joanna Wardlaw; Eric Jouvent Journal: J Cereb Blood Flow Metab Date: 2019-11-20 Impact factor: 6.200
Authors: Veronika Hanko; Alexandra C Apple; Kathryn I Alpert; Kristen N Warren; Julie A Schneider; Konstantinos Arfanakis; David A Bennett; Lei Wang Journal: Neurobiol Aging Date: 2018-10-25 Impact factor: 4.673
Authors: Jonathan Graff-Radford; Malini Madhavan; Prashanthi Vemuri; Alejandro A Rabinstein; Ruth H Cha; Michelle M Mielke; Kejal Kantarci; Val Lowe; Matthew L Senjem; Jeffrey L Gunter; David S Knopman; Ronald C Petersen; Clifford R Jack; Rosebud O Roberts Journal: Alzheimers Dement Date: 2015-10-23 Impact factor: 21.566